OptimizeRx Corp (OPRX) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
OptimizeRx Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • OptimizeRx Corp Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$6.9 M, a 7.83% decline year-over-year.
  • OptimizeRx Corp Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$18.1 M, a 28.4% decline year-over-year.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$17.6 M, a 53.6% decline from 2022.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$11.4 M, a 3125% decline from 2021.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2021 was $378 K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$18.1 M -$6.9 M -$501 K -7.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$17.6 M -$4.14 M -$3.82 M -1171% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$13.8 M -$2.87 M +$601 K +17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$14.4 M -$4.16 M -$277 K -7.12% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$14.1 M -$6.4 M -$2.64 M -70.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$11.4 M -$326 K -$949 K -152% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$10.5 M -$3.47 M -$3.51 M -8790% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$6.98 M -$3.88 M -$4.24 M -1203% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$2.75 M -$3.76 M -$3.12 M -490% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 $378 K $623 K -$734 K -54.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.11 M $39.9 K +$323 K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $789 K $352 K +$1.43 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$641 K -$637 K +$1.57 M +71.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$2.21 M $1.36 M +$3.34 M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 -$5.55 M -$283 K +$1.29 M +82% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$6.84 M -$1.08 M -$1.48 M -365% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$5.35 M -$2.2 M -$2.21 M -33856% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.14 M -$1.98 M -$1.87 M -1706% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$1.27 M -$1.57 M -$1.82 M -741% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $548 K $407 K +$126 K +45% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 $422 K $6.53 K +$196 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 $226 K -$110 K +$127 K +53.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $99.2 K $245 K +$868 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$769 K $281 K +$642 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.41 M -$189 K +$694 K +78.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.1 M -$237 K +$116 K +32.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$2.22 M -$623 K -$380 K -157% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$1.84 M -$362 K +$230 K +38.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$2.07 M -$883 K -$531 K -151% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$1.54 M -$353 K +$61.9 K +14.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$1.6 M -$243 K -$331 K -376% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$1.27 M -$592 K -$435 K -276% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$836 K -$352 K -$241 K -216% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$595 K -$415 K -$645 K -280% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $50.2 K $87.9 K +$382 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$332 K -$157 K +$42.2 K +21.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$374 K -$111 K +$651 K +85.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.03 M $231 K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$295 K +$117 K +28.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$199 K Apr 1, 2014 Jun 30, 2014 10-K/A 2015-09-16
Q1 2014 -$762 K -$538 K -240% Jan 1, 2014 Mar 31, 2014 10-K/A 2015-09-16
Q3 2013 -$412 K Jul 1, 2013 Sep 30, 2013 10-K/A 2015-09-16
Q1 2013 -$224 K +$76.3 K +25.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 -$301 K +$79.2 K +20.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q2 2011 -$433 K +$442 K +50.5% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-17
Q1 2011 -$380 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q2 2010 -$875 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.